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Abstract
Background—The National Death Index (NDI) is a centralized database containing information 
from death certificates that is frequently referenced by health and medical investigators to 
ascertain vital statistics. Yet, it commonly includes misclassified causes of death. Since the NDI is 
frequently relied upon in studies that evaluate outcomes following radical prostatectomy (RP) for 
prostate cancer (PC), we evaluated its validity by referencing mortality data from the Shared Equal 
Access Regional Cancer Hospital (SEARCH) database which is a prospectively managed database 
of 5,009 Veterans who underwent a RP at eight Veterans Affairs medical centers between 1982 
and 2016.
Methods—We compared vital status, cause of death and date of death from the SEARCH 
database with the NDI.
Results—A total of 1,312 men in SEARCH were deceased, yet the NDI reported 17% (219) of 
those men as still alive. Among the 1,093 men who had concordant vital status in both SEARCH 
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and NDI, the date of death was an exact match within one day, a week, or 31 days in 94%, 97%, 
99%, and 100%, respectively. Of those men coded as dying from prostate cancer in the SEARCH 
database (n=105), 12% were coded as having died from non-PC causes in the NDI. Meanwhile, 
among patients coded by the NDI as having died of PC (n=139), 34% were coded in SEARCH as 
having died of non-PC causes.
Conclusions—These findings demonstrate that the NDI provides accurate dates of death, but 
frequently misclassifies whether a death was due to prostate cancer. Studies that rely upon death 
certificates, as capture in the NDI, may be unreliable to report prostate cancer specific mortality 
rates after prostatectomy.
Retrospective studies that analyze mortality outcomes frequently rely on the National Death 
Index (NDI) to ascertain vital status, as well as date and cause of death.1–3 It is managed by 
the US National Center for Health Statistics, and since 1979 has been used in more than 
1,000 health research publications.4 Information on the cause of death in this database relies 
upon death certificates that frequently have classification errors, and are almost always 
completed by individuals who did not have a formal clinical relationship with the decedent. 
Yet, investigations that evaluate prostate cancer-specific mortality (PCSM) rates commonly 
reference data sources that rely upon death certificates.5–9 This is even though a review by 
medical examiners has found that up to 60% of death certificates contain errors in the 
underlying cause-of-death code.10 This high error rate has been attributed to the 
characteristics of death certifiers,11 and has led to concerns about the accuracy of cancer-
specific mortality statistics that have been found to be erroneous in the literature.12,13 
Herein, we investigate the impact of this known misclassification of cause of death on 
studies evaluating PCSM following prostatectomy.
The Shared Equal Access Regional Cancer Hospital (SEARCH) database is a retrospective, 
IRB-approved database that maintains records on 5,009 Veterans who underwent a radical 
prostatectomy (RP) at eight Veterans Affairs Medical Centers between 1982 and 2016. It is 
routinely updated with manual reviews of individual patient electronic medical records 
available through the Veterans Health Administration (VHA) that includes information on 
labs, pathology, radiology, and clinical notes, and is coded by personnel who are trained by 
the SEARCH team. Data are abstracted according to detailed guidelines that were developed 
by urologic oncologists, and 10% of cases are routinely audited to ensure the validity and 
consistency of data collection. Cause of death in the SEARCH database is coded as “prostate 
cancer” whenever there was progressive metastatic disease following hormonal therapy 
without another obvious cause of death, “other” whenever a death related to prostate cancer 
could be ruled out, and “unknown or other” whenever information was incomplete. 
Whenever in doubt, cases are reviewed by a urologic oncologist who specializes in prostate 
cancer (SJF, WJA).
We cross-referenced data from the SEARCH database coded between 1989–2011 with the 
NDI for vital status, cause of death, and date of death. Social security numbers were used to 
reconcile this information, and the analysis relied on ICD-9 codes to match the cause-of-
death. A total of 1,327 and 1,093 patients were coded as deceased in SEARCH and NDI, 
respectively. All deceased patients in the NDI were coded as dead in SEARCH, though 17% 
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(219) of deaths in SEARCH were listed as alive in the NDI (see Table 1). This rate of 
incongruence for vital status decreased to 4% after 1998 (see Figure 1). For patients with 
concordant death status, the dates were an exact match, within one day, within a week, or 
within 31 days for 94%, 97%, 99%, and 100%, respectively.
NDI and SEARCH were in concordance on 941 deaths from other causes and 92 PC deaths 
(see Table 2). However, 13 patients were misclassified by SEARCH as having died of 
prostate cancer and 47 were misclassified by NDI as dying from non-PC causes. Of the 104 
patients coded in SEARCH as dead from PC, the NDI coded 77% accurately, with 11% as 
non-PC, and 12% as alive. Of the 139 patients coded in the NDI as dead from PC, SEARCH 
confirmed 66% to be accurate, with 34% as non-PC, and 0% as alive. Dropping patients 
with an unknown cause of death in either source, the positive predictive value for PC death 
in NDI was 72% and negative predictive value was 98%.
Previous evaluations have shown variable rates of agreement between the cause of death 
coded in death certificates versus available hospital records. Uncertainties during completion 
of death certificates and transcription errors contribute to challenges in coding cause of 
death. Yet, challenges are present even in prospective clinical trials when complete clinical 
records are available. For example, the randomized PIVOT trial utilized an Endpoints 
Committee comprising an internist and two urologists to assign the cause of death. Each 
committee member was presented with “death summary packets” that included a death 
certificate; a brief report of the site investigator’s conclusions regarding cause of death; 
study PSA values; study bone scan results; and relevant medical records, including discharge 
summaries, radiology reports, and pathology reports, particularly when another type of 
cancer was suspected. Even with this amount of detailed clinical information, the committee 
members agreed in only 56% of cases before discussing whether the death was “definitely” 
or “probably” due to prostate cancer or treatment. Agreement increased to 86% when the 
“definitely” and “probably” assignments were collapsed (a strategy that was defined a 
priori), maintaining concerns about the reliability of the PCSM endpoint even in this phase 
III trial. As this experience indicates, ascertaining the of cause of death, even in a 
prospective clinical trial, can be challenging and is an inexact science. As such, there is the 
possibility of misclassification in SEARCH as well, given clinical records may be missing 
for decedents who received their care outside the VA at the end of life. There may be 
scenarios where the individuals completing death certificates had access to more meaningful 
clinical records just before death, though our results included an analysis that excluded 
patients in SEARCH that had an “unknown” cause of death.
Using cause-specific survival, as opposed to overall survival, to evaluate treatment efficacy 
has the advantage of minimizing biases introduced by competing causes of death. However, 
deaths from prostate cancer are frequently misclassified, especially in databases such as the 
NDI which rely on death certificates, and thus studies using a PCSM endpoint should be 
interpreted with caution.
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KEY POINT:
Evaluating the cause of death in patients who have undergone a prostatectomy is a 
meaningful endeavor. However, our study shows that ascertaining this information from 
the National Death Index has substantial limitations.
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Figure 1. 
Histogram showing the number of death statuses that agree between SEARCH and NDI and 
deaths missed by NDI between 1988 and 2011.
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Table 1.
Cross tabulation of death status in SEARCH vs. NDI.
NDI DEAD NDI ALIVE Total
SEARCH DEAD 1093 219 1312
SEARCH ALIVE 0 3604 3604
Total 1093 3823 4,916
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Table 2.
Cross tabulation of cause of death in SEARCH vs. NDI.
NDI PC Death NDI non-PC Death Total
SEARCH PC Death 92 13 105
SEARCH non-PC Death 47 941 988
Total 139 954 1,093
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